Hexagon Nutrition Ltd · HEXAGON · Food - Processing - Others · price as of the 18 November 2026 close, updated every trading day · results updated weekly · research updated 10 October 2026
Hexagon Nutrition share price today: ₹60.25 at the close on 18 November 2026. Hexagon Nutrition (HEXAGON) is worth ₹741 crore and trades at a P/E of 19.4.
Hexagon Nutrition Ltd's results are improving, while its P/E is near the low end of its own history over 5 months, higher than only 4% of past readings.
Biggest thing to watch: the price has already been rising for 20 weeks, so timing is the risk more than the business.
The price has been rising for 20 weeks, and the P/E is lower than 96% of its own last 5 months. Over the last four quarters, results have been improving, with profit +24.9% on a year earlier, and 91% of the last 3 years' profit came in as cash. What will decide it: the next one or two quarters of results.
What is the Hexagon Nutrition share price today?
Hexagon Nutrition Ltd's share price was ₹60.25 at the close on 18 November 2026. It has been rising for 20 weeks. That is 0.5% above its average price over the last 200 trading days. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 5 weeks running.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Hexagon Nutrition Ltd is in stage 2. The phase helps read everything below.
Since its first close in our records, on 25 June 2026, it has traded between ₹54 and ₹76, and at that close it sat 28% of the way up from that low.
Week by week since 2026: did it beat the NIFTY 500 over the past 13 weeks?
Ahead in 5 of 11 weeks
| Week | 13-week return vs NIFTY 500 |
|---|---|
| 25 Jun 2026 | no NIFTY 500 reading |
| 3 Jul 2026 | no NIFTY 500 reading |
| 10 Jul 2026 | no NIFTY 500 reading |
| 17 Jul 2026 | no NIFTY 500 reading |
| 24 Jul 2026 | no NIFTY 500 reading |
| 31 Jul 2026 | no NIFTY 500 reading |
| 7 Aug 2026 | no NIFTY 500 reading |
| 14 Aug 2026 | no NIFTY 500 reading |
| 21 Aug 2026 | no NIFTY 500 reading |
| 28 Aug 2026 | no NIFTY 500 reading |
| 4 Sep 2026 | no NIFTY 500 reading |
| 11 Sep 2026 | no NIFTY 500 reading |
| 18 Sep 2026 | no NIFTY 500 reading |
| 25 Sep 2026 | +15.4% |
| 28 Sep 2026 | −9.7% |
| 1 Oct 2026 | +2.3% |
| 9 Oct 2026 | +6.1% |
| 16 Oct 2026 | +14.5% |
| 23 Oct 2026 | +4.3% |
| 30 Oct 2026 | −8.0% |
| 6 Nov 2026 | −7.2% |
| 8 Nov 2026 | −12.0% |
| 13 Nov 2026 | −15.0% |
| 18 Nov 2026 | −12.4% |
Over the last 5 months the share price moved +5% while the NIFTY 500 moved +3%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What are Hexagon Nutrition's latest quarterly results?
For April to June 2026 (the quarter ended 30 June 2026), Hexagon Nutrition reported revenue of ₹104 crore, up 43.2% from ₹72.9 crore a year earlier, and a profit of ₹8.07 crore, up 24.9% from ₹6.46 crore.
Hexagon Nutrition results: April to June 2026 against a year earlier
| Measure | April to June 2026 | April to June 2025 | Change |
|---|---|---|---|
| Revenue | ₹104 crore | ₹72.9 crore | +43.2% |
| Profit | ₹8.07 crore | ₹6.46 crore | +24.9% |
| Earnings per share | ₹0.66 | ₹0.58 | +13.8% |
| Operating margin | 11.3% | 13.8% | −2.5 points |
The next results, for July to September 2026, were due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). This page shows them once our weekly data update has read them.
Hexagon Nutrition's management discussed these results on a call held on 14 August 2026; what it said is further down this page.
From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.
What is the Hexagon Nutrition share price history?
Hexagon Nutrition closed at ₹60.25 on 18 November 2026. Its highest weekly close since June 2026 was ₹73.39 on 3 July 2026.
Hexagon Nutrition share price: then and now
| When | Close | Change to 18 Nov 2026 |
|---|---|---|
| 1 week ago · 11 Nov 2026 | ₹59.99 | +0.4% |
| 1 month ago · 19 Oct 2026 | ₹68.55 | −12.1% |
| Earliest weekly close in our records · 25 Jun 2026 | ₹57.49 | +4.8% |
| Highest weekly close since June 2026 · 3 Jul 2026 | ₹73.39 | −17.9% |
| Lowest weekly close since June 2026 · 30 Oct 2026 | ₹54.11 | +11.3% |
Weekly closing prices. Each change is the move from that price to the 18 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.
24 weekly closes from 25 June 2026 to 18 November 2026.
What is the latest news on Hexagon Nutrition?
18 Nov 2026: Hexagon Nutrition closed at ₹60.25, up 0.4% on the week and down 12.1% on the month. Our read, 10 Oct 2026: Premix demand and executable orders provide operating fuel; their contribution must be counted together rather than treated as separate profit sources. Input inflation, freight and distribution spending are absorbing part of the revenue benefit. The case depends on recovering cash conversion and margins, with earnings quality still partly unexplained.
Earlier
- 15 Sep 2026: ex-date for a dividend of ₹0.30 a share.
- 14 Aug 2026: Hexagon Nutrition held its results call for April to June 2026. Management guided: FY27 revenue growth of 20-25%; described as conservative.
- Results for April to June 2026: Revenue up 43.2% and profit up 24.9% on a year earlier.
Our read of the business
Premix demand and executable orders provide operating fuel; their contribution must be counted together rather than treated as separate profit sources. Input inflation, freight and distribution spending are absorbing part of the revenue benefit. The case depends on recovering cash conversion and margins, with earnings quality still partly unexplained.
April to June 2026: Volume growth outpaced profit as input costs and expansion spending absorbed the benefit.
Our read after the April to June 2026 results, written 10 October 2026.
What dividend does Hexagon Nutrition pay?
Hexagon Nutrition paid ₹0.30 a share in regular dividends in the 12 months to 18 November 2026 (1 payment), a yield of 0.50% at the ₹60.25 close on 18 November 2026. The last was a dividend of ₹0.30 a share, ex-date 15 September 2026.
Hexagon Nutrition dividends since 1 April 2021
| Ex-date | Dividend per share | Type |
|---|---|---|
| 15 Sep 2026Dividend | ₹0.30 | Dividend |
Amounts as the company declared them on the exchange. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.
No. Hexagon Nutrition Ltd paid out 0% of its profit as dividends in each of its last 7 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate.
From the exchange corporate-actions record, read 18 November 2026.
What did Hexagon Nutrition management say on the latest results call?
On the call for April to June 2026, held on 14 August 2026, Hexagon Nutrition's management guided: FY27 revenue growth of 20-25%; described as conservative.
“This year, we will maintain the same growth trajectory that we posted last year. We will try to maintain a growth range of around 20-25%.”Mr. Vikram Kelkar, Managing Director, on the call for April to June 2026
What management guided
- ₹100 crore current order book to execute in Q2 and partly Q3, with no Q2 slowdown expected.
- ESG pipeline of ₹75-100 crore for FY27.
- Branded/B2C revenue mix to reach 35% within the next couple of years.
- Selected branded-product MRP increases expected to support margins from Q2 and through the next two quarters; exact percentage unclear on the call.
Management’s own plans and goals, from our notes of the call. A plan is not a result.
Source: the call transcript.
From the call for April to June 2026, 14 August 2026.
What is the future of Hexagon Nutrition? What is changing in the business?
What is changing at Hexagon Nutrition, from the latest results and calls: premix order conversion, branded distribution productivity and selected price increases.
- Premix order conversion. Existing production headroom can turn volume demand into shipments without immediate capacity expansion. ✓ fact
- Branded distribution productivity. A wider field force can improve branded sales if incremental distribution spending produces repeat demand. ✓ fact
- Selected price increases. Realized pricing can recover part of the input-cost squeeze if demand lasts. ✓ fact
- Tender-backed nutrition demand. Orders already in production provide a dated test of program demand. ⚠ estimate
We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.
Our read after the April to June 2026 results, written 10 October 2026.
What is Hexagon Nutrition's order book?
Management's current order book was summarized at 100 crore for execution in Q2 and partly Q3.
✓ fact
Our read after the April to June 2026 results, written 10 October 2026.
What could change the Hexagon Nutrition story? What are the risks?
Orders are delayed or cancelled, or shipments increase without enough contribution margin to cover incremental costs.
Each change stops working if
- Premix order conversion: Orders are delayed or cancelled, or shipments increase without enough contribution margin to cover incremental costs.
- Selected price increases: Input inflation exceeds realized price recovery or higher prices reduce profitable demand.
- Tender-backed nutrition demand: Tender awards, production or customer payments slip beyond the scheduled execution period.
The main risks
- The other-income contribution remains unexplained. ⚠ estimate
- Latest annual cash conversion weakened despite a better aggregate history. ⚠ estimate
- The explanation of geopolitical input-cost exposure changed. ⚠ estimate
- Redevelopment borrowing precedes evidence of its return. ⚠ estimate
Our read after the April to June 2026 results, written 10 October 2026.
What to watch in Hexagon Nutrition's next results?
When Hexagon Nutrition reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Near-term order execution - test whether the current order book converts without the stated slowdown.
Management raised each of these on the latest results call.
- Near-term order execution - test whether the current order book converts without the stated slowdown.
- Gross-margin recovery - test price pass-through against raw-material inflation and freight pressure.
- Nashik redevelopment - monitor progress plus any impairment, disposal or salvage disclosure.
- Working-capital conversion - verify continued receivables recovery and inventory normalization in the next balance-sheet disclosure.
Which stock lists is Hexagon Nutrition on?
Hexagon Nutrition is not on any of our India lists this week.
Is Hexagon Nutrition profitable?
Hexagon Nutrition Ltd earned ₹8.1 Cr of net profit in the Jun 2026 quarter, +24.9% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹38.0 Cr. Over 6 years profit has grown 32.6% a year on average. The same quarter a year earlier earned ₹7.8 Cr.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
The Jun 2026 quarter's profit is 7.7% of that quarter's revenue.
For the full year, FY26 profit was ₹38.0 Cr (+58.3% on the year before).
How much revenue does Hexagon Nutrition make, and is it growing?
Hexagon Nutrition Ltd reported ₹104 Cr of revenue in the Jun 2026 quarter, +43.2% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 6 years it has grown 25.1% a year on average. The last full year, FY26, came in at ₹380 Cr.
Revenue is everything the company billed its customers in the period.
Why this happened. The Value Chain Climb applies to the intended shift toward branded nutrition. Management has expanded field coverage and named a future mix objective. the profit benefit remains a forecast until representative productivity, repeat purchases and realized segment contribution improve. The latest consolidated margin does not prove that the company retains the benefit. Competitor response and channel economics are not quantified.
FY26 revenue was ₹380 Cr, +17.3% on the year before.
Recent pace: the last four quarters grew +25.6% on average, against 25.1% a year over the longer run, so this year is growing at about the same pace as its own long-run rate.
How much of every ₹100 of sales does Hexagon Nutrition keep?
Hexagon Nutrition Ltd's operating margin was 11.3% in the Jun 2026 quarter, 2.5 percentage points lower than the same quarter a year ago. Over the last four quarters it has moved −0.6 percentage points. Across 7 years it has been between −0.9% and 16.1%. The latest quarter is within that range.
Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why this happened. The Input Cost Pass-Through Test separates an announced price increase from pricing power. Management expects selected branded price changes to support margins, but supplies no quantified recovery bridge. The benefit depends on realized realised prices exceeding incremental input and freight costs after discounts, channel incentives and any volume loss. Evidence of customer acceptance and competitors' next response is currently absent.
Why the margin moved: operating margin changed −0.6 percentage points on the year while gross margin changed +3.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged.
Watch next
- Metric
- Selected price increases
- Threshold
- Input inflation exceeds realized price recovery or higher prices reduce profitable demand.
- Which result
- the next result
Is Hexagon Nutrition's profit turning into cash?
Over the last 3 years, 91% of Hexagon Nutrition Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹6.0 Cr of operating cash against ₹38.0 Cr of profit.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
After ₹7.0 Cr of spending on assets, free cash was −₹1.0 Cr: it spent more than its operations brought in.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
Why 91% of profit came in as cash: the cash cycle got 31 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.
What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.
Where does Hexagon Nutrition's cash go?
Hexagon Nutrition Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 179 days in FY26, up from 148 days in FY21. It spent ₹31.0 Cr on assets over the last 3 years. Customers take 79 days to pay, and stock sits for 153 days on average.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
Why this happened. Management describes premix growth as volume-led and identifies orders scheduled for the coming reporting periods. Orders, utilization and premix volume are dependent links in the same mechanism, so their profit contribution is counted once. Revenue has already benefited; the remaining opportunity is timely conversion with adequate realized margins. Customer procurement decisions and tender timing control part of the outcome.
At FY26 sales of ₹380 Cr, each day of that cycle ties up about ₹1.0 Cr, so roughly ₹186 Cr is tied up in the business at any time.
FY26: customers took 79 days to pay and stock sat for 153 days, about 5.0 months of sales sitting as stock, for a full cycle of 179 days, longer than FY21's 148.
The full loop: cash goes out to suppliers and production on day 0. Stock sits for 153 days. Customers pay about 79 days after that. Suppliers are paid at 53 days. Together that makes the 179-day cycle.
Spending on assets: ₹31.0 Cr over the last 3 years, against ₹27.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹3.0 Cr (FY26): assets paid for that are not earning yet.
In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.
Watch next
- Metric
- Premix order conversion
- Threshold
- Orders are delayed or cancelled, or shipments increase without enough contribution margin to cover incremental costs.
- Which result
- the next result
What is Hexagon Nutrition's P/E ratio, and how does it compare with its own history?
Hexagon Nutrition Ltd's P/E is 19.4×, near the low end of its own history: it has been lower only 4% of the time. Its usual P/E (the middle reading) is 22.0×, over 5 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.
In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.
Is the Hexagon Nutrition business getting better or worse?
Hexagon Nutrition Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 4 quarters of 1 measure, with some gaps.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Why it matters: with too little history, we say so rather than guess a direction.
One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.
The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.
There are fewer than eight usable quarters, so this page does not guess a direction from so little history.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | +17.3% | +49.4% | +12.5% | — |
| Profit | +58.3% | — | +10.6% | — |
| EPS | +55.9% | — | +10.6% | — |
What is the Hexagon Nutrition story, and has it been checked?
Hexagon Nutrition Ltd's story is not scored yet against the checks our research set on 10 October 2026. Where it sits in its own cycle: mid expansion.
NOT YET CHECKED
From the numbers. The current weekly classification remains unclassified because history is insufficient. The normalization verdict is…
From the price. Price stage 2, week 20, below its 200-day line.
Where they disagree. The current weekly classification remains unclassified because history is insufficient. The normalization verdict is NA SHORT MARGIN HISTORY.
What the company does. Premix demand and executable orders provide operating fuel; their contribution must be counted together rather than treated as separate profit sources. Input inflation, freight and distribution spending are absorbing part of the revenue benefit. The case depends on recovering cash conversion and margins, with earnings quality still partly unexplained.
The key numbers to watch, and the level that would change the picture
| Measure | Why it matters | What to watch |
|---|---|---|
| Premix order conversion | Existing production headroom can turn volume demand into shipments without immediate capacity expansion. | Orders are delayed or cancelled, or shipments increase without enough contribution margin to cover incremental costs. |
| Branded distribution productivity | A wider field force can improve branded sales if incremental distribution spending produces repeat demand. | — |
| Selected price increases | Realized pricing can recover part of the input-cost squeeze if demand lasts. | Input inflation exceeds realized price recovery or higher prices reduce profitable demand. |
| Tender-backed nutrition demand | Orders already in production provide a dated test of program demand. | Tender awards, production or customer payments slip beyond the scheduled execution period. |
Everything further down this page is evidence for or against these.
FY26-Q1FY27-Q1
What the surface reading misses. The surface reading is: Rapid revenue growth could suggest broad earnings acceleration. The research reads it further: Revenue grew faster than operating profit because margin compression absorbed part of the volume benefit. Margin Inflection vs. Revenue Growth points to sales-led growth with cost offsets, rather than a margin-led earnings surge.
What the surface reading misses. The surface reading is: Profit outgrowing revenue suggests improved operating leverage. The research reads it further: Operating profit did outgrow revenue, but net profit increased faster still. The operating improvement is observable; the residual contribution from non-operating income, interest and tax is not fully decomposable from the supplied fields.
- 1 · Operating leveragequiet
- 2 · Value-added mixquiet
- 3 · Management changequiet
- 4 · Paying down debtquiet
- 5 · Regulatory approvalquiet
- 6 · Order-book winsbuilding
- 7 · Consolidationquiet
- 8 · Demerger or value unlockquiet
- 9 · Buybackquiet
- 10 · New geographiesquiet
- 11 · More business from existing customersquiet
- 12 · New product launchquiet
- 13 · Mandatory normsquiet
- 14 · A bigger market to servequiet
- 15 · Market-share gainsquiet
- 16 · Asset qualityquiet
Lever 6 · Order-book wins: building. Orders already in production provide a dated test of program demand. What proves it keeps working: Tender-backed nutrition demand. It stops working if Tender awards, production or customer payments slip beyond the scheduled execution period.
Sources: our stock research file (10 October 2026) · quarterly results through Jun 2026 · the company’s own earnings calls. The story check is re-scored every results season; the record below never changes.
The whole page in one table. Each row links to its section.
Did Hexagon Nutrition management deliver what it promised?
What Hexagon Nutrition Ltd's management promised, against what actually happened: 1 promise on the record. Read straight from the company’s own earnings calls. A promise that slipped stays on this page after it is met.
West Asia Impact Narrative Reversed · 14 August 2026. In Jul 2026, management said the West Asian geopolitical situation had not significantly affected the business or raw-material sourcing. In Aug 2026, management both reiterated that there was no material business impact in its prepared remarks and attributed the gross-margin contraction to the West Asia crisis, stating that the resulting raw-material cost increase had materially impacted the company. This conflicting explanation of the same risk is material for assessing margin resilience and management's forecasting credibility.
Every quote above is taken word for word from the company’s own earnings calls.
How much does Hexagon Nutrition earn on its capital?
Hexagon Nutrition Ltd earned a ROCE of 22% in FY26. That is up from a low of 2% in FY23. Its return on capital used (ROIC) is 3.6 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 10.0% net margin and 1.19× asset turnover (sales divided by assets).
Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.
Why the return is what it is (FY26): a 10.0% net margin × 1.19× asset turnover × 1.36× leverage (assets divided by equity) ≈ 16.2% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.
The key test, return on capital used minus the cost of capital: 15.6% − 12.0% = +3.6 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.
The 15.6% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 16.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.
Does Hexagon Nutrition have too much debt?
Hexagon Nutrition Ltd has total debt of ₹33.0 Cr against shareholder equity of ₹233 Cr as of Mar 2026, so its debt is 0.14× its equity, which is very little. Year by year, that ratio went from 0.26 in FY22 to 0.14 in FY26. So the returns on this page come from the business, not from borrowed money.
Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.
What is the Hexagon Nutrition shareholding pattern?
No group of Hexagon Nutrition Ltd's owners changed its stake by a full percentage point over the last 2 quarters. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.
Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.
How far is Hexagon Nutrition from balance-sheet trouble?
For Hexagon Nutrition Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
How does Hexagon Nutrition rank in its industry?
57.6 out of 100, rank 3 of 4 in Food - Processing - Others, with 37% of the evidence available. It is provisional, so it is ranked below companies with full evidence.
Hexagon Nutrition Ltd scores 57.6 out of 100 against the 4 companies it is compared with in Food - Processing - Others, ranking 3. Some evidence is missing, so the score is pulled toward the middle on purpose.
The three scored parts add up to the total exactly: 19.5 + 25.6 + 12.5 = 57.6 (no relative-strength reading this week; its 20 points are shared across the other three). This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Hexagon Nutrition compared with?
Hexagon Nutrition ranks 3 of 4 Food - Processing - Others companies on the 4-Factor Sector Score, with 57.6 out of 100.
- 1Apis India LtdAPIS · quiet · Too little evidence to rank firmly · 53% evidence46.2out of 100
How the score adds up
Growth & earnings 15.4/35 · Revenue 2.8% · Profit 9.3% · Operating margin change 1.1 points · 83% evidenceCapital efficiency 13.3/25 · ROCE 14.6% (year to Mar 2026) · Operating margin 9.4% · 76% evidenceValuation 10.0/20 · P/E 29× · PEG — · 0% evidenceRelative strength 7.5/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -13.3% · 1 year 18.1% · 25% evidence · 2 of 7 weeks aheadExact sum: 15.4 + 13.3 + 10 + 7.5 = 46.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. - 2Euro India Fresh Foods LtdEIFFL · quiet · Too little evidence to rank firmly · 56% evidence43.9out of 100
How the score adds up
Growth & earnings 18.4/35 · Revenue 5.5% · Profit 69.7% · Operating margin change 10.1 points · 74% evidenceCapital efficiency 8.0/25 · ROCE 9.8% (year to Mar 2026) · Operating margin 12.7% · 100% evidenceValuation 10.0/20 · P/E 90.2× · PEG — · 0% evidenceRelative strength 7.5/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -10.8% · 1 year 2.1% · 25% evidence · 3 of 12 weeks aheadExact sum: 18.4 + 8 + 10 + 7.5 = 43.9 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. - 3Hexagon Nutrition Ltd this pageHEXAGON · quiet · Too little evidence to rank firmly · 37% evidence57.6out of 100
How the score adds up
Growth & earnings 19.5/43.75 · Revenue — · Profit — · Operating margin change -2.5 points · 34% evidenceCapital efficiency 25.6/31.25 · ROCE 21.8% (year to Mar 2026) · Operating margin 11.3% · 100% evidenceValuation 12.5/25 · P/E 19.4× · PEG — · 0% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 19.5 + 25.6 + 12.5 = 57.6 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. - 4Pajson Agro India Ltdturning · Too little evidence to rank firmly · 33% evidence52.9out of 100
How the score adds up
Growth & earnings 18.0/43.75 · Revenue — · Profit — · Operating margin change -5 points · 26% evidenceCapital efficiency 22.4/31.25 · ROCE 31.4% (year to Mar 2026) · Operating margin 13.3% · 95% evidenceValuation 12.5/25 · P/E 33.7× · PEG — · 0% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 18 + 22.4 + 12.5 = 52.9 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Food - Processing - Others, all 4 compared on one page.
Which companies are close to Hexagon Nutrition in size?
Hexagon Nutrition is the 2nd largest of 4 Food - Processing - Others companies on Sector Alpha by market value (at the 18 November 2026 close). Just above it: Pajson Agro India. Just below it: Apis India and Euro India Fresh Foods.
Food - Processing - Others companies close in size
- Pajson Agro India Ltd ₹778 crore
- Hexagon Nutrition Ltd ₹741 crore
- Apis India Ltd ₹714 crore
- Euro India Fresh Foods Ltd ₹587 crore
All 4 Food - Processing - Others companies, largest first
Companies close in size in other industries
- Indo SMC Ltd ₹742 crore · Electric Equipment - General
- Shree Rama Multi-Tech Ltd ₹742 crore · Packaging - Laminates
- Hexagon Nutrition Ltd ₹741 crore
- NCL Industries Ltd ₹741 crore · Cement
- Ecos (India) Mobility & Hospitality Ltd ₹740 crore · Services - Others
What else do people ask about Hexagon Nutrition?
What were Hexagon Nutrition's latest quarterly results?
Hexagon Nutrition Ltd reported revenue of ₹104 Cr and net profit of ₹8.1 Cr for the Jun 2026 quarter. Revenue rose 43.2% and profit rose 24.9% compared with a year earlier. Earnings per share were ₹0.66.
The operating margin was 11.3%, 2.5 percentage points lower than a year earlier (as of 18 November 2026).
What is Hexagon Nutrition's market cap?
Hexagon Nutrition Ltd's market capitalisation is ₹741 Cr at a share price of ₹60.25. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 18 November 2026).
How is Hexagon Nutrition performing?
Hexagon Nutrition Ltd's share price has been rising for 20 weeks. In its latest quarter, revenue rose 43.2% and profit rose 24.9% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 5 weeks running (as of 18 November 2026).
Will Hexagon Nutrition's share price go up?
This page does not forecast Hexagon Nutrition Ltd's share price. What it shows instead: the share price is ₹60.25, and it has been rising for 20 weeks. Its P/E of 19.4× is higher than 4% of its own last 0 years (as of 18 November 2026).
Who owns Hexagon Nutrition?
Promoters own 64.4% of Hexagon Nutrition Ltd, foreign institutions 0.3%, domestic institutions 4.1% and the public 31.2% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 18 November 2026).
Where is Hexagon Nutrition in its business cycle?
Hexagon Nutrition Ltd's FY26 operating margin was 13.9%, against a 7-year range of −0.9% to 16.1%. The latest quarter was 11.3%, the middle of its own range, neither a peak nor a low.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 18 November 2026).
What could break the Hexagon Nutrition story?
Biggest thing to watch: the price has already been rising for 20 weeks, so timing is the risk more than the business.
On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 18 November 2026).
Is Hexagon Nutrition a stock worth studying right now?
What the numbers show: Hexagon Nutrition Ltd's results are improving, while its P/E is near the low end of its own history over 5 months, higher than only 4% of past readings. The main open question: the next one or two quarters of results.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 18 November 2026).
Is there a Hexagon Nutrition share price forecast for 2026?
What management itself guided: FY27 revenue growth of 20-25%; described as conservative. What is changing at Hexagon Nutrition, from the latest results and calls: premix order conversion, branded distribution productivity and selected price increases.
What would change the story: Orders are delayed or cancelled, or shipments increase without enough contribution margin to cover incremental costs.
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 18 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.